A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity. - Wikidata - wikimedia - TriplyDB

A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity.

A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity.

http://www.wikidata.org/entity/Q37694673

about

A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity.

http://www.wikidata.org/entity/Q37694673

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A functional signal profiling ...... ified HER2 signaling activity.

@en

A functional signal profiling ...... ified HER2 signaling activity.

@nl

type

label

A functional signal profiling ...... ified HER2 signaling activity.

@en

A functional signal profiling ...... ified HER2 signaling activity.

@nl

prefLabel

A functional signal profiling ...... ified HER2 signaling activity.

@en

A functional signal profiling ...... ified HER2 signaling activity.

@nl

P1433

Q37694673-64B7F074-2C1D-4176-B37A-2726FCF59F28

P1476

Q37694673-7230F634-D1A8-47DE-A549-3D5C774D387F

P2093

Q37694673-05E5270E-249C-40AB-811F-9EF482627CA6

Q37694673-2431AD46-F558-4D2F-B70A-1124232A529F

Q37694673-2CFA0DF3-4B6D-4CD3-B9FC-74F257DB77C0

Q37694673-4EE88904-5D03-4A13-A39B-913A1888FDE7

Q37694673-5451D52D-D6FE-4472-8775-DB6FCEE30D73

Q37694673-704BF389-93FF-4DFD-B42E-C37C2BB39245

Q37694673-7BD52D6D-63C4-44E5-A84C-C57DF9547389

Q37694673-7D8C95B9-F2FC-4D24-AA9C-45A7F3B4DC28

Q37694673-D930A4A7-85C7-45E3-B6F4-30DE4FC31252

Q37694673-DC3E71B3-EF15-4647-9E1D-069A2A3FBE6C

P2860

Q37694673-02964B4C-7154-482A-9DE7-7C7536CEF38D

Q37694673-07FE77BA-6FBF-4C34-A8CA-356DB56F0058

Q37694673-0808FD42-1333-4417-B820-BF1588FB2ECE

Q37694673-0C75834C-FA41-47C2-B5B2-762AE930DFF8

Q37694673-16716052-D371-4BF6-9AC0-C9B8B8853F5B

Q37694673-19C4D251-313F-4892-AAC9-29D02733C468

Q37694673-264C43C2-C50F-4AD7-89D1-B5BB2E6A75F9

Q37694673-309D08F7-3CA5-4946-AA46-348357363C9B

Q37694673-35CBA667-FE6C-4169-A531-84F5D0B059AE

Q37694673-3F422D28-D911-4806-B976-54A15DD31A5B

P304

Q37694673-E6F0B11A-0CAA-4A5C-8118-F96D7F394115

P31

Q37694673-57FB68A6-D272-4D8C-8CDC-316CCBDA3283

P356

Q37694673-D07924B9-F855-4064-A20D-3C561ED33399

P407

Q37694673-45016EE4-E5AA-4FCE-BE91-F8F3768393A8

P433

Q37694673-746221F6-8294-4F3C-A505-42AF95847309

P478

Q37694673-E99DDE30-69B2-4215-8344-89F47DE523B2

P577

Q37694673-5C1669F8-6D73-44B4-8512-9141403B9754

P698

Q37694673-91647C41-647E-4D6D-B4A2-D44BA76F11D2

P932

Q37694673-36FFCFC4-5660-4F45-91B0-9452950D5B3D

P356

ONCOTARGET.12480

P1433

P1476

A functional signal profiling ...... ified HER2 signaling activity.

@en

P2093

Abhijit Dandapat

http://www.w3.org/2001/XMLSchema#string

Benjamin E Rich

http://www.w3.org/2001/XMLSchema#string

Brian F Sullivan

http://www.w3.org/2001/XMLSchema#string

Carol A Lange

http://www.w3.org/2001/XMLSchema#string

David J Burns

http://www.w3.org/2001/XMLSchema#string

Ian A MacNeil

http://www.w3.org/2001/XMLSchema#string

Lance G Laing

http://www.w3.org/2001/XMLSchema#string

Leo T Furcht

http://www.w3.org/2001/XMLSchema#string

Sajjad M Soltani

http://www.w3.org/2001/XMLSchema#string

Samantha Myhre

http://www.w3.org/2001/XMLSchema#string

P2860

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

Activating HER2 mutations in HER2 gene amplification negative breast cancer

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects

Label-free and real-time cell-based kinase assay for screening selective and potent receptor tyrosine kinase inhibitors using microelectronic sensor array.

Discovery and validation of breast cancer subtypes

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation

Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications

P304

78577-78590

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.12480

http://www.w3.org/2001/XMLSchema#string

P407

P433

48

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27713176

http://www.w3.org/2001/XMLSchema#string

P932

5346661

http://www.w3.org/2001/XMLSchema#string